Cargando…
Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in mice
We previously showed that intrathecal administration of methotrexate slowed disability progression in multiple sclerosis (MS) patients with progressive disease. In general MS patients with progressive disease respond poorly to anti-inflammatory therapies. In order to better understand the mechanism...
Autores principales: | Mueller, Andre M., Nassery, Adam, Conlon, Hana, Liu, Xinhe, Jun, Esther, Yoon, Bo Hyung, Cristofanilli, Massimiliano, Sadiq, Saud A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797440/ https://www.ncbi.nlm.nih.gov/pubmed/24137109 http://dx.doi.org/10.3389/fnmol.2013.00034 |
Ejemplares similares
-
Clozapine administration enhanced functional recovery after cuprizone demyelination
por: Templeton, Nikki, et al.
Publicado: (2019) -
Strain differences in cuprizone induced demyelination
por: Yu, Qili, et al.
Publicado: (2017) -
A New Model of Cuprizone-Mediated Demyelination/Remyelination
por: Sachs, Hilary H., et al.
Publicado: (2014) -
Cuprizone does not induce CNS demyelination in nonhuman primates
por: Chen, Zhihong, et al.
Publicado: (2015) -
Dock3 protects myelin in the cuprizone model for demyelination
por: Namekata, K, et al.
Publicado: (2014)